Lino Fabio L, Traina Évelyn, Barreto José Augusto, Moron Antonio Fernandes, Mattar Rosiane
Department of Obstetrics, Universidade Federal de São Paulo, São Paulo, Brazil Colsan Associação Beneficente de Coleta de Sangue, São Paulo, Brazil
Department of Obstetrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Clin Appl Thromb Hemost. 2015 May;21(4):365-72. doi: 10.1177/1076029613520465. Epub 2014 Jan 24.
Generally, recurrent spontaneous abortions (RSAs) have no identifiable cause; yet, vascular alterations during pregnancy may be associated with pregnancy loss. Therefore, we evaluated the association between thrombophilic mutations and RSAs. This case-control study was conducted in 112 patients who had RSAs and 98 health control women. Genomic DNA was extracted from whole blood, and polymorphism genotyping was conducted using polymerase chain reaction. The following 6 genetic variants were analyzed: factor V Leiden, prothrombin mutation, methylenetetrahydrofolate reductase C677T and A1298C, plasminogen activator inhibitor type 1 (4G>5G), and factor XIII G103T (V34L). No correlations were found in any of the investigated polymorphisms. Moreover, 35.0% of cases and 25.5% of controls had at least 2 mutations in combination, and 4.8% of cases and 5.1% of controls had 3, but these combinations were not associated with additional risk. In conclusion, we found no association between the polymorphisms studied and the occurrence of RSAs.
一般来说,复发性自然流产(RSA)没有可识别的原因;然而,孕期血管改变可能与流产有关。因此,我们评估了血栓形成倾向突变与RSA之间的关联。本病例对照研究纳入了112例RSA患者和98名健康对照女性。从全血中提取基因组DNA,并使用聚合酶链反应进行多态性基因分型。分析了以下6种基因变异:凝血因子V莱顿突变、凝血酶原突变、亚甲基四氢叶酸还原酶C677T和A1298C、纤溶酶原激活物抑制剂1型(4G>5G)以及凝血因子XIII G103T(V34L)。在所研究的任何多态性中均未发现相关性。此外,35.0%的病例和25.5%的对照至少有2种突变组合,4.8%的病例和5.1%的对照有3种突变组合,但这些组合与额外风险无关。总之,我们发现所研究的多态性与RSA的发生之间没有关联。